TrialCancer medicine2019

A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer.

Zishuo Ian Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.